Clinical trial for a better treatment for mycetoma starts in Sudan
Clinical trial for a better treatment for mycetoma starts in Sudan
[Khartoum, Sudan – 19 June 2017] First ever double-blind study for disease so neglected that it only recently was added to WHO list of neglected tropical diseases The first-ever double-blind, randomized clinical trial for an effective treatment for the severely neglected disease mycetoma has enrolled its first patient at the Mycetoma Research Centre (MRC) in Khartoum, Sudan.
Clinical trial for a better treatment for mycetoma starts in Sudan
GARDP at one: R&D programmes getting underway
GARDP at one: R&D programmes getting underway
GARDP has set up its team, scientific advisory committee, and R&D strategy. Three programmes are underway: neonatal sepsis, gonorrhoea, and an initiative to recover and connect the vital knowledge of scientists in antibiotic drug development. In recent weeks, both the G20 Health Ministers and outgoing WHO Director-General Margaret Chan have expressed support for GARDP and called for more R&D into drug-resistant infections.
GARDP at one: R&D programmes getting underway
NTD Summit 2017: this is not (yet) the endgame
NTD Summit 2017: this is not (yet) the endgame
Bernard Pécoul, Executive Director, DNDi [May 2017] Ambitious targets serve the obvious purpose of galvanising the NTD community around a shared goal, and the London Declaration succeeded in bringing new actors to the table and casting a much-needed spotlight on the neglect of these diseases. But the job is far from done, and we should not be lulled into a sense of security or complacency by too much celebrating of good news.
NTD Summit 2017: this is not (yet) the endgame
New open source project engages universities in neglected diseases drug discovery
New open source project engages universities in neglected diseases drug discovery
[London and New York –  May 3, 2017] Indian, UK and US students to help discover desperately-needed drug leads for visceral leishmaniasis The non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) has launched a collaborative project with five universities in India, the UK, and the US to harness the capacity of university teaching laboratories and task students with discovering potential new drugs for patients living with neglected diseases.
New open source project engages universities in neglected diseases drug discovery
See all news

Scientific Articles

See all scientific articles

Events

  • WorldLeish 6

    6th World Congress on Leishmaniasis

    May 16-20, 2017 Toledo, Spain The WHO ColIaborating Centre for Leishmaniasis at the Instituto de Salud Carlos III, Madrid and the Drugs for Neglected Diseases initiative, Geneva joined efforts to co-organize the WorldLeish-6 Congress.
  • 2nd Symposium on Medicinal Chemistry for Global Health June 18-20, 2017 GlaxoSmithKline, Tres Cantos, Madrid, Spain Ben Perry, NTD Drug Discovery Booster Project Manager and Charles Mowbray, Head of Discovery, DNDi, presented on the NTD Discovery Booster, aminopyrazoles and NTDs.
  • IAS 2017

    9th IAS Conference on HIV Science

    July 23-26, 2017 Paris, France Isabelle Andrieux-Meyer, Paediatric HIV/HCV Team Leader at DNDi, will present on DNDi's work on HCV.
  • XXV Brazilian Parasitology Congress September 3-6, 2017 Búzios, Rio de Janeiro, Brazil DNDi will present an abstract on LOLA hit-to-lead results.
See all events